Key Takeaway: Nautilus Biotechnology, Inc. announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference set for September 4, 2024, in New York. Management will engage in a fireside chat, which highlights the company's growing presence in the healthcare sector. The event indicates Nautilus's efforts to enhance investor relations and promote its innovative proteome analysis platform. Interested individuals can access a live and archived webcast of the presentation on the company's website.
Price reaction · baseline $2.29 (2024-08-13 close) · hit after-hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close · peak
-2.2%
Market Sentiment Analysis
POSITIVE FACTORS
Nautilus is participating in a major healthcare conference, increasing visibility.
The company is pioneering a unique single-molecule proteome analysis platform.
The participation may attract potential investors or partnerships.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder
Full Press Release Details
SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced the company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York.
Nautilus management is scheduled to participate in a fireside chat on Wednesday, September 4, 2024, at 7:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Frequently Asked Questions
When will Nautilus Biotechnology participate in the healthcare conference?
Nautilus Biotechnology will participate in the conference on September 4, 2024.
How can I access Nautilus’ presentation at the conference?
You can access the presentation via a webcast on the company's website.
Where is Nautilus Biotechnology headquartered?
Nautilus Biotechnology is headquartered in Seattle, Washington.
What is Nautilus Biotechnology’s mission?
Nautilus aims to democratize access to the proteome and advance human health.